Yuvraj Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 0.47 M
- Company Age 10 Year, 2 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 1.00 Cr
- Satisfied Charges ₹ 7.00 M
- Revenue Growth 39.29%
- Profit Growth 80.74%
- Ebitda 58.28%
- Net Worth 27.51%
- Total Assets 23.07%
About Yuvraj Pharmaceuticals
Yuvraj Pharmaceuticals Private Limited (YPPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 20 December 2014 and has a history of Ten years and two months. Its registered office is in Delhi, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.47 M.
The company currently has active open charges totaling ₹1.00 Cr. The company has closed loans amounting to ₹7.00 M, as per Ministry of Corporate Affairs (MCA) records.
Sakshi and Sushma Malik serve as directors at the Company.
Company Details
- Location
Delhi, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U52100DL2014PTC274392
- Company No.
274392
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
20 Dec 2014
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Who are the key members and board of directors at Yuvraj Pharmaceuticals?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sakshi  | Director | 20-Dec-2014 | Current |
| Sushma Malik | Director | 20-Dec-2014 | Current |
Financial Performance of Yuvraj Pharmaceuticals.
Yuvraj Pharmaceuticals Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 39.29% increase. The company also saw a substantial improvement in profitability, with a 80.74% increase in profit. The company's net worth Soared by an impressive increase of 27.51%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Yuvraj Pharmaceuticals?
In 2022, Yuvraj Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Santom Hospital Private LimitedSushma Malik is a mutual person
Lens 2 Home Private LimitedSushma Malik is a mutual person
Om Institute & Research LlpSakshi and Sushma Malik are mutual person
- Rpm Financial Services Private Limited
Sushma Malik is a mutual person
- Santom Hospital & Diagnostics Private Limited
Sushma Malik is a mutual person
Charges (Loans)
₹10.00 M
₹7.00 M
Charges Breakdown by Lending Institutions
- The South Indian Bank Limited : 1.00 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 31 Mar 2018 | The South Indian Bank Limited | ₹1.00 Cr | Open |
| 15 Jun 2018 | The South Indian Bank Limited | ₹1.00 M | Satisfied |
| 28 Sep 2015 | Others | ₹6.00 M | Satisfied |
How Many Employees Work at Yuvraj Pharmaceuticals?
Unlock and access historical data on people associated with Yuvraj Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Yuvraj Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Yuvraj Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.